The city of Dallas, Texas, currently has 13 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
A Study to Investigate Leramistat in Patients With IPF
Recruiting
To compare the effect of daily oral dosing of leramistat over 12 weeks with placebo in participants aged 40 years or older with idiopathic pulmonary fibrosis (IPF).
Gender:
ALL
Ages:
40 years and above
Trial Updated:
02/16/2024
Locations: Baylor Scott and White Health - Advanced Lung Disease Specialists - Dallas, Dallas, Texas
Conditions: Idiopathic Pulmonary Fibrosis